Search Articles
Filter Articles
Sections
- All (3,079 articles)
- Pharma Events (45 articles)
- For Recruiters (233 articles)
- Careers Events (5 articles)
- Partners (3 articles)
- News (2,565 articles)
- Careers Advice (261 articles)
- Company Focus (109 articles)
- Company Career Hubs (1 article)
- Pharma Training (6 articles)
- 25 Years of PharmiWeb (13 articles)
- DE&I (1 article)
Found 3,079 articles
BioPharma Companies Recognised in 2024 UK’s Best Workplaces™ List
- 21 Mar 2024
Employees from top biopharma companies such as AbbVie, AXON and Aspire Scientific are amongst the 250,000 UK personnel who surveyed with Great Place To Work® UK. Using the data gathered from the research-backed and anonymous employee experience surveys, Great Place To Work has announced its annual UK’s Best Workplaces™ list.
About Cambridge Cognition
- 21 Mar 2024
Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health.
How much can a Clinical Trials Manager earn in the UK?
- 20 Mar 2024
Discover the latest salary trends for clinical trials managers in the UK with our guide. How does location and experience impact earnings potential and help you plan your career path.
Bayer and Thermo Fisher Scientific collaborate to increase patient access to precision cancer medicines
- 20 Mar 2024
Bayer AG and Thermo Fisher Scientific Inc. today announced to develop next-generation sequencing (NGS)-based companion diagnostic assays (CDx) together.
CHARAC ACQUIRES LEADING PRESCRIPTION DELIVERY MANAGEMENT SYSTEM PDM
- 20 Mar 2024
Charac, a leading healthcare SaaS provider, today announces the acquisition of Pro Delivery Manager (PDM), a leading prescription delivery management system, from its shareholders, which include the National Pharmacy Association (NPA).
-
Rise in BME and disabled leaders encouraging but challenges remain
- 20 Mar 2024
Responding to the publication of NHS Workforce Race Equality Standard (WRES) and Workforce Disability Equality Standard (WDES) Joan Saddler, director of partnerships and equality at the NHS Confederation...
Global Life Science Agency Appoints Chief Financial Officer
- 20 Mar 2024
International specialist marketing and commercial growth agency, ramarketing has announced a senior leadership appointment as it continues to expand globally.
About Seqera
- 20 Mar 2024
Seqera makes complex data analysis accessible at any scale by providing the tools to drive innovation in genomics, global health, and beyond.
Seqera appoints Melinda Pautsch as Chief Revenue Officer
- 20 Mar 2024
Seqera, the leading software provider for data analysis in the life sciences space, today announced the appointment of Melinda Pautsch as its Chief Revenue Officer (CRO). The appointment marks a significant step in the company's growth journey, as it focuses on strengthening its market position as the open science platform of choice and delivering value for customers across the Nextflow ecosystem.
China unveils ChatGPT-like medical chatbot service
- 20 Mar 2024
Hong Kong-based Centre for Artificial Intelligence and Robotics (CAIR) under the Chinese Academy of Sciences (CAS), one of China's national research institutes, has developed a large language model-based chatbot to assist doctors in making medical diagnoses and treatments.
A Recruiter’s Guide to Hiring a Clinical Research Associate (CRA)
- 15 Mar 2024
In this guide, we explore the essential steps and considerations for you to keep in mind when searching for a Clinical Research Associate (CRA). From understanding the unique demands of the role to identifying key competencies and conducting effective interviews, this guide will provide you with valuable tips to help you focus your candidate search and engage top talent.
Invest in Equality, Diversity and Inclusion, urge health leaders
- 14 Mar 2024
Health leaders believe investing in equality, diversity and inclusion (EDI) roles is key to improving the NHS.
About Amolyt Pharma
- 14 Mar 2024
Amolyt Pharma, a clinical stage biotechnology company, is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases.
Takeda Announces Positive Topline Results from Phase 2 Study Evaluating Mezagitamab (TAK-079), a Potential Best-in-Class Anti-CD38 Monoclonal Antibody, for Primary Immune Thrombocytopenia
- 14 Mar 2024
Takeda (TSE:4502/NYSE:TAK) today announced positive topline results from a Phase 2, randomized, double-blind, placebo-controlled study evaluating the safety, tolerability and efficacy of mezagitamab (TAK-079) in patients with persistent or chronic primary immune thrombocytopenia (ITP).
AstraZeneca to acquire Amolyt Pharma, expanding late-stage rare disease pipeline
- 14 Mar 2024
AstraZeneca announced that it has entered into a definitive agreement to acquire Amolyt Pharma, a clinical-stage biotechnology company focused on developing novel treatments for rare endocrine diseases.
New AI model detects ninety percent of lymphatic cancer cases
- 14 Mar 2024
Medical image analysis using AI has developed rapidly in recent years. Now, one of the largest studies to date has been carried out using AI-assisted image analysis of lymphoma, cancer of the lymphatic system. Researchers at Chalmers University of Technology in Sweden, have developed a computer model that can successfully find signs of lymph node cancer in 90 percent of cases.
About Recursion
- 13 Mar 2024
Recursion is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest proprietary biological, chemical and patient-centric datasets.
What do Clinical Research Organisations Do?
- 13 Mar 2024
Clinical Research Organisations (CROs) play a crucial role in advancing medical knowledge and therapeutic innovations. As vital intermediaries between pharmaceutical and biotechnology companies, healthcare professionals, and regulatory bodies, CROs help facilitate the clinical development of new drugs, devices, and treatments.
Merck Announces Plans to Conduct Clinical Trials of a Novel Investigational Multi-Valent Human Papillomavirus (HPV) Vaccine and Single-Dose Regimen for GARDASIL ® 9
- 13 Mar 2024
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today, at the EUROGIN 2024 HPV Congress, announced plans to initiate clinical development of a new investigational multi-valent HPV vaccine designed to provide broader protection against multiple HPV types.
New Data to be Presented for BioMarin's VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
- 13 Mar 2024
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced that positive early results from an investigator-sponsored Phase 2 study of VOXZOGO® (vosoritide) in children with hypochondroplasia, will be presented at the 2024 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting in Toronto, Canada, March 12-16, 2024.
